The present invention relates to formulations comprising combinations of
analgesic/anti-inflammatory, immunomodulating and
cartilage-reconstructing agents in particular comprising saligenig,
boswellic acid, procyanidins, N-acety-glucosamine and either glucoronic
acid or glucoronolactone, for the treatment of rheumatoid arthritis and,
more generally, of arthritis conditions.